Intest Res.  2017 Jul;15(3):263-265. 10.5217/ir.2017.15.3.263.

Could adalimumab be used safely and effectively in intestinal Behçet's disease refractory to conventional therapy?

• Park J
• Cheon JH

• KMID: 2382371
• DOI: http://doi.org/10.5217/ir.2017.15.3.263

Abstract

No abstract available.

MeSH Terms

Adalimumab*
Adalimumab

Reference

1. Kim DH, Cheon JH. Intestinal Behçet's disease: a true inflammatory bowel disease or merely an intestinal complication of systemic vasculitis? Yonsei Med J. 2016; 57:22–32. PMID: 26632379.

2. Choi CH, Moon W, Kim YS, et al. Second Korean guidelines for the management of ulcerative colitis. Intest Res. 2017; 15:7–37. PMID: 28239313.

3. Lee JH, Cheon JH, Jeon SW, et al. Efficacy of infliximab in intestinal Behçet's disease: a Korean multicenter retrospective study. Inflamm Bowel Dis. 2013; 19:1833–1838. PMID: 23702810.

4. Tanida S, Inoue N, Kobayashi K, et al. Adalimumab for the treatment of Japanese patients with intestinal Behçet's disease. Clin Gastroenterol Hepatol. 2015; 13:940–948.e3. PMID: 25245624.

5. Hisamatsu T, Ueno F, Matsumoto T, et al. The 2nd edition of consensus statements for the diagnosis and management of intestinal Behçet's disease: indication of anti-TNFalpha monoclonal antibodies. J Gastroenterol. 2014; 49:156–162. PMID: 23955155.

6. Cheon JH. Understanding the complications of anti-tumor necrosis factor therapy in East Asian patients with inflammatory bowel disease. J Gastroenterol Hepatol. 2017; 32:769–777. PMID: 27723166.

7. Inoue N, Kobayashi K, Maganuma M, et al. Long-term safety and efficacy of adalimumab for intestinal Behçet's disease in the open label study following a phase 3 clinical trial. Intest Res. 2017; 15:395–401.

8. Warner B, Harris AW. Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis. Gastroenterology. 2012; 143:e42. DOI: 10.1053/j.gastro.2012.03.055.

9. Colombel JF, Schwartz DA, Sandborn WJ, et al. Adalimumab for the treatment of fistulas in patients with Crohn's disease. Gut. 2009; 58:940–948. PMID: 19201775.

10. Matsumoto T, Motoya S, Watanabe K, et al. Adalimumab monotherapy and a combination with azathioprine for Crohn's disease: a prospective, randomized trial. J Crohns Colitis. 2016; 10:1259–1266. PMID: 27566367.